Navigating Global Policy: Current CRISPR Technology Market Trends in Regulatory Harmonization
The global regulatory environment for gene editing is a patchwork of varying standards, but 2026 is seeing the first real steps toward harmonization. As CRISPR-based therapies for rare diseases move closer to commercialization, health authorities in the US, EU, Japan, and China are beginning to share clinical trial data to speed up the approval process. This "mutual recognition" of data is...
0 Comments 0 Shares 6 Views 0 Reviews
MakeMyFriends https://makemyfriends.com